Relationship Between Oral Amiodarone and Inappropriate Therapy From an Implantable Cardioverter Defibrillator
スポンサーリンク
概要
- 論文の詳細を見る
Background: This study evaluated the efficacy of amiodarone for avoiding inappropriate therapies by implantable cardioverter defibrillators (ICDs). Methods and Results: A total of 232 patients with structural heart disease (58±13 years; 78% males) who underwent an initial ICD implantation were retrospectively investigated to compare baseline characteristics and event rates of inappropriate ICD therapy delivery between patients with oral amiodarone therapy (amiodarone group, n=116) and those without (non-amiodarone group, n=116). During a mean follow-up of 29±21 months, inappropriate therapies occurred less frequently in the amiodarone group than in the non-amiodarone group (12% vs 27%, P=0.0068). As a cause of inappropriate ICD therapy, only atrial fibrillation (AF) significantly differed between the groups (3% vs 12%, P=0.01). The results of multivariate logistic regression analysis showed that amiodarone therapy (odds ratio (OR) 0.38, 95% confidence interval (CI) 0.19-0.77, P=0.0073) and no history of spontaneous AF (OR 0.27, 95%CI 0.13-0.57, P=0.0007) were independent predictors of a lower risk of inappropriate ICD therapy. Conclusions: In the present group of ICD patients with structural heart disease, inappropriate therapy delivery occurred predominantly in those with spontaneous AF and/or without amiodarone. (Circ J 2010; 74: 1302 - 1307)
論文 | ランダム
- CK-2-1 ミリ波CMOS増幅器(CK-2.ミリ波実用化に向けたデバイス・回路・システム技術の現状と将来,ソサイエティ特別企画,ソサイエティ企画)
- CK-2-1 ミリ波CMOS増幅器(CK-2.ミリ波実用化に向けたデバイス・回路・システム技術の現状と将来,ソサイエティ企画)
- B-17-6 直交変調器および直交復調器の誤差推定方法のEVM特性評価(B-17. ソフトウェア無線,一般セッション)
- Integrated CMOS circuits and antennas for millimeter-wave communication systems (第21回 回路とシステム軽井沢ワークショップ論文集) -- (ミリ波技術の動向と今後の展望(2))
- C-2-29 プリント基板実装60GHz帯CMOS受信ICの評価(C-2.マイクロ波A(マイクロ波・ミリ波能動デバイス),一般講演)